Only one study showed that SAMD13 is negatively associated with invasive micropapillary carcinoma of breast cancer, especially micropapillary area [13], but its clinical impact on cancers remains totally unclear, even contrary. This evidence concerns the gene SAMD13 and breast carcinoma.